Jeroen Hagendoorn

Jeroen Hagendoorn received his MD in 2003 from Utrecht University. He subsequently pursued a research fellowship in mechanisms of lymphatic function and metastasis at the Steele Laboratory for Tumor Biology at Harvard Medical School/Massachusetts General Hospital in Boston, U.S. (Prof Rakesh Jain). He received his PhD cum laude from Utrecht University in 2006 (Prof Inne Borel Rinkes). Between 2006 and 2012 he completed Surgical Residency (UMC Utrecht, St. Antonius Hospital, and Antoni van Leeuwenhoek), receiving board certification in surgical oncology and gastro-intestinal surgery. Thereafter, he started a two-year fellowship in hepato-pancreato-biliary surgery at UMC Utrecht (prof Inne Borel Rinkes) that also included an observership at the HPB Service of Memorial Sloan-Kettering Cancer Center (Dr Yuman Fong). Since 2015, he is an attending HPB surgeon at the surgical oncology dept. of UMC Utrecht Cancer Center.  Within the regional academic cancer center Utrecht "RAKU", HPB surgery is performed in a joint practice with the Antonius Hospital in Nieuwegein. Since Nov. 2025, he is appointed as full professor of surgery with a chair in the subject of translational surgical oncology.

His main clinical research interest is robotic surgery of the liver and pancreas. Together with his partner Quintus Molenaar, he was the first in The Netherlands to perform robotic partial hepatectomy and robotic Whipple resections. Currently he has over a decade of experience with robotic HPB surgery (incl. robotic resection of posterior segments, hemihepatectomy, bile duct resection, hepatic arterial infusion pump placement and whipple/distal pancreatectomy) and serves as an international proctor for robotic liver surgery.

His main laboratory research interest is mechanisms of metastasis in colorectal cancer and the liver lymphatic system, 3D chip modeling of liver/lung mircoenvironments and cancer, and the biological effect of radio-embolization on liver hypertrophy in HCC (RALLY trials). This research line is carried out in the Laboratory for Translational Oncology (Prof Onno Kranenburg) at UMC Utrecht Cancer Center.